SI-BONE, Inc.
SI-BONE, Inc. (SIBN) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · SIBN · as of Jun 8, 2026
Key Statistics
Explore SI-BONE, Inc. Data
sibn stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 9 · Buy rate: 100.0%
The SIBN analyst consensus is Buy, based on ratings from 9 Wall Street analysts over the past 3 months. The average 12-month price target is $26.00, representing +73.68% upside from the current price of $14.97.
Competitors & Peers
sibn competitorsSIBN
AIRS
AQST
AVNS
AVXL
BFLYStock Performance
Full HistoryAbout SI-BONE, Inc.
SI-BONE, Inc. is a medical technology company that develops and markets specialized implantable solutions for musculoskeletal conditions affecting the sacropelvic region. These devices are utilized ac…
what is si-bone, inc. · sibn stock overview · si-bone, inc. company profile · who is si-bone, inc. ceo · sibn NASDAQ · si-bone, inc. headquarters · si-bone, inc. business segments
About Stock Overview & Key Data
SI-BONE, Inc. (SIBN) is a Healthcare company in the Medical - Devices industry, listed on NASDAQ since Oct 17, 2018. As of the latest trading session, SIBN stock price is $14.97, with a market capitalization of $663.9M. The stock has returned -20.10% over the past 12 months and -23.59% year-to-date.
According to 9 Wall Street analysts, the consensus rating for SI-BONE, Inc. stock is Buy, with an average 12-month price target of $26.00. In fiscal year 2025, SI-BONE, Inc. reported revenue of $200.9M and net income of -$18.9M. For detailed data — including SI-BONE, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, SI-BONE, Inc. (SIBN) stock price is $14.97. The stock is traded on NASDAQ under the ticker symbol SIBN. The 52-week range is $11.48 – $21.89.